The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis-Reference-Cited by-同舟云学术

The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis

Published:2019-05-31 Issue:2 Volume:50 Page:204-214
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Mecci Ali Jibran¹^ORCID,Kemos Polychronis¹,Leen Clifford²,Lawson Adam³,Richardson Paul⁴,Khakoo Salim I.⁵^ORCID,Agarwal Kosh⁶^ORCID,Mutimer David⁷,Rosenberg William M.⁸^ORCID,Foster Graham R.¹,Irving William L.⁹^ORCID,

Affiliation:

1. Blizard Institute, Queen Mary University of London; London UK

2. University of Edinburgh; Edinburgh UK

3. Royal Derby Hospital; Derby UK

4. Royal Liverpool and Broadgreen University Hospitals NHS Trust; Liverpool UK

5. University of Southampton; Southampton UK

6. King’s College Hospital; London

7. University of Birmingham; Birmingham UK

8. University College Hospital; London UK

9. NIHR Nottingham Biomedical Research Centre; Nottingham University Hospitals, NHS Trust and the University of Nottingham; Nottingham UK

Funder

Medical Research Foundation

NHS England

LAP Research UK

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15296/fullpdf

Reference32 articles.

1. Curing chronic hepatitis C-the arc of a medical triumph;Chung;N Engl J Med,2014

2. Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis;Cheung;J Hepatol,2016

3. Sofosbuvir and velpatasvir for HCV genotype 2 and 3 Infection;Foster;N Engl J Med,2015

4. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication;van der Meer;J Hepatol,2017

5. EASL recommendations on treatment of hepatitis C 2016;European Association for the Study of the Liver;J Hepatol,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet count as a predictor of vascular invasion and extrahepatic metastasis in hepatocellular carcinoma: A systematic review and meta-analysis;Heliyon;2024-03

2. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?;Viruses;2023-12-17

3. Residual risk of hepatocellular carcinoma development for chronic hepatitis C patients treated by all oral direct-acting antivirals with sustained virological response;Journal of the Chinese Medical Association;2023-07-19

4. Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study;Biomedicines;2023-01-09

5. Hepatocellular carcinoma after treatment of hepatitis C with direct-acting antivirals: a critical re-appraisal;Hepatoma Research;2023